Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Topline overall survival (OS) results from the TROPION-Lung01 phase 3 trial, which previously met the dual primary endpoint of progression-free survival (
AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
07:00am, Thursday, 23'rd May 2024
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Alexion, AstraZeneca Rare Disease, will showcase 14 studies, including real-world evidence (RWE), from their portfolio and pipeline of investigationa
CAMBRIDGE, Mass. , May 22, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody d
Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
12:52pm, Wednesday, 22'nd May 2024
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes?
AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024
07:00am, Wednesday, 22'nd May 2024
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading portfolio and pipeline at the American Society of Clinical Oncolo
AstraZeneca: Leading banks hail Soriot's $80bn target; more detail sought
06:53am, Wednesday, 22'nd May 2024
Shares in AstraZeneca PLC (LSE:AZN) were trading just off their all-time high as leading analysts provided a largely positive assessment of its growth plans, the highlight of which was a 2030 revenue
AstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'
05:50pm, Tuesday, 21'st May 2024
AstraZeneca's (AZN) American depositary receipts (ADRs) rose over 2% to a record high Tuesday after the Anglo-Swedish drug maker announced what it called its “bold ambition” for future growth.
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
01:36pm, Tuesday, 21'st May 2024
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
AstraZeneca's new 2030 targets are bold attempt to reach for the stars, say analysts
09:11am, Tuesday, 21'st May 2024
After AstraZeneca PLC (LSE:AZN) unveiled new sales and profit targets for the end of the decade, analysts were mildly impressed by the ambition to "shoot for the stars". Starting with the bare numbe
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
04:38am, Tuesday, 21'st May 2024
Pharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including cancer treatments.
AstraZeneca kicks off ‘new era of growth' with aim to hit $80 billion of sales by 2030
04:19am, Tuesday, 21'st May 2024
AstraZeneca on Tuesday outlined ambitions to almost double its sales over the next six years by launching 20 new medicines by 2030.
AstraZeneca aims to boost revenues to $80bn by 2030
03:15am, Tuesday, 21'st May 2024
AstraZeneca PLC (LSE:AZN) aims to grow its revenue by about 75% to $80 billion by 2030, driven by the launch of 20 new medicines and growth in its oncology, biopharmaceuticals, and rare disease portfo
AstraZeneca aims to deliver $80 billion in total revenue by 2030
02:14am, Tuesday, 21'st May 2024
AstraZeneca laid out its target to deliver $80 billion in total revenue by 2030 on Tuesday, boosted by the expected launch of 20 new medicines and through growth in its existing oncology, biopharmaceu
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
02:00am, Tuesday, 21'st May 2024
CAMBRIDGE, England--(BUSINESS WIRE)--Investor Day 2024.
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
01:34pm, Monday, 20'th May 2024
Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the media focuses on attaining wealth, that doesn't mean much if you don't have he
